Prabir Roy-Chaudhury MD, PhD, FRCP (Edin), is a professor of medicine at the University of Arizona Health Sciences. He is also the director of the Division of Nephrology and the director of the Arizona Kidney and Vascular Center at the UA College of Medicine – Tucson. After graduating from the Armed Forces Medical College, in Pune, India, he trained in internal medicine and nephrology at the University of Aberdeen in Scotland, and at the Beth Israel Hospital/Harvard Medical School in Boston. In addition to being an active transplant nephrologist, Dr. Roy-Chaudhury is a member of the UA BIO5 Institute, where his main research interest is in uremic vascular biology (including both dialysis vascular access dysfunction and cardiovascular disease in kidney disease patients). He explores these studies through the Arizona Kidney and Vascular Center, which is a comprehensive, integrated, multi-disciplinary translational research program that includes basic science, clinical science and patient care components. This translational research program is funded through the National Institutes of Health, the Veterans Administration research program and through industry grants. Dr. Roy-Chaudhury has received national and international awards, has published over 150 peer reviewed manuscripts and is a sought after invited speaker, both nationally and internationally.
Dr. Roy-Chaudhury also has been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis as a board member/councilor/committee chair for the American Society of Diagnostic and Interventional Nephrology, the Renal Network, the Interventional Nephrology Advisory Group of the American Society of Nephrology (ASN), the Cincinnati chapter of the National Kidney Foundation and the Medical Advisory Board of the Life Center (Ohio). He is a member of the ASN Board of Advisors and Capitol Hill advocacy team, the ASN Postgraduate Education Committee and the International Society of Nephrology-India and South Asia Committees, as well as being the president of the American Nephrologists of Indian Origin (ANIO). Dr. Roy-Chaudhury is also the ASN co-chair of the Kidney Health Initiative, which is a public-private partnership between the ASN and the U.S. Food and Drug Administration that aims to bring together nephrologists, industry partners, patient advocacy groups and regulatory agencies in an attempt to facilitate the passage of drugs, devices and biologics into the kidney disease space.
Dr. Roy-Chaudhury has given more than 250 invited lectures and written more than 150 papers, a dozen book chapters and over 200 abstracts on his work related to nephrology, hemodialysis and vascular access as well as related efforts to develop novel devices and therapies to improve the quality of life for kidney failure patients. His current research includes NIH, VA Merit Review, NSF and FDA funding as well as support from W.L. Gore and other private industry sources.